LGALS3 and early-onset autosomal dominant Alzheimer disease: Modified citrus pectin (MCP) exerts its effects by inhibiting galectin-3, thereby downregulating the TLR4/MyD88/NF-κB signaling pathways implicated in Alzheimer’s disease.